HK1214600A1 - Phosphorus-containing pyrido[2,3-d]pyrimidin-7-ones or their pharmaceutically acceptable salts, pharmaceutical compositions containing this compound and use thereof [23-d]-7- - Google Patents

Phosphorus-containing pyrido[2,3-d]pyrimidin-7-ones or their pharmaceutically acceptable salts, pharmaceutical compositions containing this compound and use thereof [23-d]-7-

Info

Publication number
HK1214600A1
HK1214600A1 HK16102474.3A HK16102474A HK1214600A1 HK 1214600 A1 HK1214600 A1 HK 1214600A1 HK 16102474 A HK16102474 A HK 16102474A HK 1214600 A1 HK1214600 A1 HK 1214600A1
Authority
HK
Hong Kong
Prior art keywords
pyrimidin
phosphorus
ones
compound
pharmaceutically acceptable
Prior art date
Application number
HK16102474.3A
Other languages
Chinese (zh)
Inventor
呂慧敏
Original Assignee
Shandong Huiruidi Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Huiruidi Biotechnology Co Ltd filed Critical Shandong Huiruidi Biotechnology Co Ltd
Publication of HK1214600A1 publication Critical patent/HK1214600A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16102474.3A 2014-08-13 2016-03-03 Phosphorus-containing pyrido[2,3-d]pyrimidin-7-ones or their pharmaceutically acceptable salts, pharmaceutical compositions containing this compound and use thereof [23-d]-7- HK1214600A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410397283.8A CN105330699B (en) 2014-08-13 2014-08-13 A kind of phosphorous pyrido [2,3-d] pyrimidin-7-ones class compound or its pharmaceutically acceptable salt, pharmaceutical composition and its application

Publications (1)

Publication Number Publication Date
HK1214600A1 true HK1214600A1 (en) 2016-07-29

Family

ID=55281487

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102474.3A HK1214600A1 (en) 2014-08-13 2016-03-03 Phosphorus-containing pyrido[2,3-d]pyrimidin-7-ones or their pharmaceutically acceptable salts, pharmaceutical compositions containing this compound and use thereof [23-d]-7-

Country Status (4)

Country Link
CN (1) CN105330699B (en)
HK (1) HK1214600A1 (en)
TW (1) TW201605882A (en)
WO (1) WO2016023401A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106905315B (en) * 2017-03-02 2019-09-27 北京工业大学 Tetrahydropyridine simultaneously [3,4-d] pyrimidines and its preparation method and application
CN109280014A (en) * 2018-09-05 2019-01-29 成都百事兴科技实业有限公司 Trans-4-amino-cyclohexanecarboxylic acid carbethoxy hydrochloride preparation method
CN114901664A (en) * 2020-01-10 2022-08-12 江苏先声药业有限公司 Pyridone compound and application thereof
WO2022109001A1 (en) 2020-11-18 2022-05-27 Deciphera Pharmaceuticals, Llc Gcn2 and perk kinase inhibitors and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06003996A (en) * 2003-10-08 2006-07-05 Irm Llc Compounds and compositions as protein kinase inhibitors.
EP1761540B1 (en) * 2004-05-13 2016-09-28 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
GB0510390D0 (en) * 2005-05-20 2005-06-29 Novartis Ag Organic compounds
JO2660B1 (en) * 2006-01-20 2012-06-17 نوفارتيس ايه جي PI-3 Kinase inhibitors and methods of their use
AP2710A (en) * 2006-09-15 2013-07-30 Pfizer Prod Inc Pyrido (2, 3-D) Pyrimidinone compounds and their use as P13 inhibitors
PE20090717A1 (en) * 2007-05-18 2009-07-18 Smithkline Beecham Corp QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS
WO2011146882A1 (en) * 2010-05-21 2011-11-24 Intellikine, Inc. Chemical compounds, compositions and methods for kinase modulation
CN106619647A (en) * 2011-02-23 2017-05-10 因特利凯有限责任公司 Combination of mtor inhibitors and pi3-kinase inhibitors and uses thereof
BR112013025798A2 (en) * 2011-04-08 2016-12-20 Afraxis Holdings Inc 8-ethyl-6- (aryl) pyrido [2,3-d] pyrimidin-7 (8h) -ones for the treatment of cancer and nervous system disorders

Also Published As

Publication number Publication date
CN105330699B (en) 2018-12-04
CN105330699A (en) 2016-02-17
WO2016023401A1 (en) 2016-02-18
TW201605882A (en) 2016-02-16

Similar Documents

Publication Publication Date Title
IL250158A0 (en) Naphthyridine and isoquinoline derivatives, their preparation and pharmaceutcal compositions containing them
FI3674298T3 (en) Substituted indazoles, process for their preparation, pharmaceutical formulations containing them, and their use for the preparation of medicaments
HK1231416A1 (en) Complexes of sirolimus and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
ZA201705112B (en) Salt of a pyrimido[6,1-a]isoquinolin-4-one compound
IL250267A0 (en) Indolizine derivatives, their preparation and pharmaceutical compositions containing them
HK1247203A1 (en) Substituted imidazo [1, 2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
IL273740A (en) Pharmaceutical oral formulation comprising bacteria
PT3421038T (en) Naphthyridine compound, pharmaceutical composition and use thereof
IL262204A (en) Granule formulation for oral administration
HK1255313A1 (en) Stabilized pharmaceutical composition containing pemetrexed or pharmaceutically acceptable salt thereof
HK1214600A1 (en) Phosphorus-containing pyrido[2,3-d]pyrimidin-7-ones or their pharmaceutically acceptable salts, pharmaceutical compositions containing this compound and use thereof [23-d]-7-
HK1243351A1 (en) Pharmaceutical composition comprising pyridopyrimidine derivative or pharmaceutically acceptable salt thereof
HUP1400104A2 (en) Compositions comprising indometacine, its pharmaceutically acceptable salts and cocrystals; and process for the preparation
HUP1600415A2 (en) Pimavanserin salts for the manufacture of pharmaceutical formulations
EP3227292A4 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
EP3162368A4 (en) Pharmaceutical composition for oral administration
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
EP3222271A4 (en) Stable pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salt thereof
HUP1600436A2 (en) Salts for the preparation of a pharmaceutical composition
HUP1400520A2 (en) Laquinimod salts useful for the preparation of pharmaceutical compositions
HUP1400105A2 (en) Compositions comprising nanostructured ibuprofen, its pharmaceutically acceptable salts and cocrystals, and process for the preparation
AU2014904868A0 (en) 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS
HUP1400103A2 (en) Compositions comprising nanostructured rosuvastatin, its pharmaceutically acceptable salts and cocrystals and process for the preparation